论文部分内容阅读
目的观察Ⅲ型前列腺炎患者经中西医结合治疗的效果。方法 102例Ⅲ型前列腺炎患者,采用随机数字表法将患者分为对照组和观察组,每组51例。对照组给予盐酸坦索罗辛缓释胶囊治疗,观察组在此基础上给予中成药治疗,比较两组疗效。结果治疗后,两组患者慢性前列腺炎症状评分表(NIH-CPSI)评分均较治疗前显著降低,对比差异具有统计学意义(P<0.05),且观察组NIH-CPSI评分明显低于对照组,对比差异具有统计学意义(P<0.05);观察组患者的治疗总有效率为92.16%,对照组为76.47%,对比差异具有统计学意义(P<0.05)。结论在Ⅲ型前列腺炎患者的治疗中,与单纯应用盐酸坦索罗辛缓释胶囊治疗相比,联合应用中成药治疗可明显提高疗效,具有较高的临床实践价值。
Objective To observe the effect of type Ⅲ prostatitis treated by Chinese and Western medicine. Methods A total of 102 patients with type Ⅲ prostatitis were randomly divided into control group and observation group with 51 cases in each group. The control group was treated with tamsulosin hydrochloride sustained-release capsules, and the observation group was treated with proprietary Chinese medicines on the basis of the above results. The curative effect was compared between the two groups. Results After treatment, the scores of NIH-CPSI in both groups were significantly lower than those before treatment (P <0.05), and NIH-CPSI scores in the observation group were significantly lower than those in the control group , The difference was statistically significant (P <0.05). The total effective rate of the observation group was 92.16% and that of the control group was 76.47%, the difference was statistically significant (P <0.05). Conclusion In the treatment of type Ⅲ prostatitis patients, compared with the simple application of tamsulosin hydrochloride sustained-release capsules, the combined application of proprietary Chinese medicines can significantly improve the therapeutic effect, which has high clinical value.